Cargando…
Combination of long-acting TRAIL and tumor cell-targeted photodynamic therapy as a novel strategy to overcome chemotherapeutic multidrug resistance and TRAIL resistance of colorectal cancer
Chemotherapeutic multidrug resistance (MDR) is the major hindrance for clinical therapy of colorectal cancer (CRC). Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) with selective cytotoxicity might overcome MDR of CRC cells. Unfortunately, cross-resistance to TRAIL has been detected...
Autores principales: | She, Tianshan, Shi, Qiuxiao, Li, Zhao, Feng, Yanru, Yang, Hao, Tao, Ze, Li, Heng, Chen, Jie, Wang, Shisheng, Liang, Yan, Cheng, Jingqiu, Lu, Xiaofeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7977453/ https://www.ncbi.nlm.nih.gov/pubmed/33754061 http://dx.doi.org/10.7150/thno.51193 |
Ejemplares similares
-
A novel tumor-homing TRAIL variant eradicates tumor xenografts of refractory colorectal cancer cells in combination with tumor cell-targeted photodynamic therapy
por: Li, Zhao, et al.
Publicado: (2022) -
Overcoming TRAIL Resistance for Glioblastoma Treatment
por: Deng, Longfei, et al.
Publicado: (2021) -
Endogenous IgG-based affinity-controlled release of TRAIL exerts superior antitumor effects
por: Yang, Hao, et al.
Publicado: (2018) -
Trailing TRAIL Resistance: Novel Targets for TRAIL Sensitization in Cancer Cells
por: Trivedi, Rachana, et al.
Publicado: (2015) -
Targeting c-Met Receptor Overcomes TRAIL-Resistance in Brain Tumors
por: Du, Wanlu, et al.
Publicado: (2014)